Akebia saponin D
SIGMA/SML1822 - ≥98% (HPLC)
Synonym: 3-O-α-L-arabinopyranosyl hederagenin-28-β-D-glucopyranoside-(1→6)-β-D-glucopyranoside; ASD; Asperosaponin VI; Leiyemudanoside A; Tauroside St-G0-1
CAS Number: 39524-08-8
Empirical Formula (Hill Notation): C47H76O18
Molecular Weight: 929.10
Linear Formula: C47H76O18
Product Type: Chemical
assay | ≥98% (HPLC) |
biological source | (Dipsacus asper) |
color | white to beige |
form | powder |
InChI | 1S/C47H76O18/c1-42(2)13-1 |
InChI key | CCRXMHCQWYVXTE-HMRSNRLKSA |
optical activity | [α]/D +13 to +18°, c = 0.5 in methanol |
Quality Level | 100 |
shipped in | wet ice |
SMILES string | CC1(C)CC[C@]2(C(O[C@@H]3O |
solubility | H2O: 3 mg/mL, clear (warmed) |
storage condition | desiccated |
storage temp. | −20°C |
Biochem/physiol Actions: | Akebia saponin D (ASD) is a bioactive triterpenoid saponin isolated from the rhizome of Dipsacus asper Wall that is used as an anti-osteoporosis drug. Akebia saponin D exhibits therapeutic effects in number of disease models including cancer, Alzheimer′s disease, cardiovascular disease, and bone fractures. Akebia saponin D protects against nonalcoholic fatty liver disease (NAFLD) liver damage in mice model of NAFLD. ASD decreases hepatic steatosis and heptocyte apoptosis through autophagy modulation. Akebia saponin D prevents oleic acid induced lipid droplets accumulation and increases autophagic flux BRL cells. |
Packaging: | 5, 25 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | −20°C |
UNSPSC | 12352200 |